# Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19

> **NCT04357990** · NA · COMPLETED · sponsor: **Kerecis Ltd.** · enrollment: 128 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Viruxal Oral and Nasal Spray
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04357990
- **Lead sponsor:** Kerecis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-04
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04357990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04357990, "Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04357990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*